A key feature of these tumors was the clustering of highly proliferative tumor cells in vascular islands, where the MAPK/ERK/CDK2 signaling pathway was active, more active than in control SHP2+ tumors (Figure 2C, Figure 3, A–C, Figure 4, and Supplemental Figure 2B). The gene discussed is PTPN11; the disease is neoplasm.